Startup finalists competed in four tracks: biopharma; devices and diagnostics; health tech aimed at consumers and self-insured employers; and health tech aimed at payers and providers. Investor judges in each track selected the winners.
Healthcare experts shared key principles that are guiding health system strategy during a panel at MedCity News’ INVEST conference. These leaders believe in flexible, patient-centered engagement strategies, emphasize clinical value as the benchmark for adopting technology, and champion collaboration to scale solutions that deliver proven results.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
To scale clinical AI, vendors must design tools that feel natural and personalized to each doctor — otherwise, clinicians won’t use them, said Heidi Health CEO Tom Kelly. In the crowded AI scribe market, he believes that clinician adoption rates, not flashy integration or deployment speeds, are the true measure of success.
Apnimed’s obstructive sleep apnea drug reduced breathing interruptions in a Phase 3 clinical trial. The once-nightly pill, which is based on research from Brigham and Women’s Hospital, activates muscles that keep the upper airway open during sleep.
Sprinter Health's $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel.
Israeli cancer diagnostics startup SpotitEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners.
In a webinar sponsored by fintech business Mercury, investors from Breyer Capital and MBX Capital shared their startup trend perspectives on AI, valuation, and alternative funding.
Healthtech companies have to navigate a maze of complex regulations, prove their financial model, and win over multiple stakeholders. Finding the right balance between patient protection and innovation is crucial.
Riverside Health is reporting an increase in revenue and net margins as a result of adopting Abridge’s ambient AI technology. The tool listens to doctor-patient interactions and generates clinical notes — which not only alleviates physicians’ burnout, but also improves their documentation accuracy. The Virginia-based health system saw a 14% increase in HCC diagnoses documented per encounter.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California.
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency and personalized communication.
HAYA Therapeutics’ drugs hit targets in the dark genome, the part of the genome that does not code for proteins but plays a key role in regulating gene expression. With the Series A funding, the startup will enter Phase 1 with a genetic medicine addressing fibrosis that leads to a type of heart failure.
Cedars-Sinai and Redesign Health launched a new innovation center seeking to build digital health startups from the ground up. These startups will focus on four main areas: care access, personalized medicine, provider workflows and care coordination.
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.